These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 37088066)

  • 1. Specific fetal malformations following intrauterine exposure to antiseizure medication.
    Vajda F; O'Brien T; Graham J; Hitchcock A; Perucca P; Lander C; Eadie M
    Epilepsy Behav; 2023 May; 142():109219. PubMed ID: 37088066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The teratogenesis risk associated with antiseizure medication duotherapy in women with epilepsy.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Perucca P; Lander CM; Eadie MJ
    Epilepsy Res; 2024 Feb; 200():107316. PubMed ID: 38340680
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Lancet Neurol; 2018 Jun; 17(6):530-538. PubMed ID: 29680205
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Associations between particular types of fetal malformation and antiepileptic drug exposure in utero.
    Vajda FJ; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    Acta Neurol Scand; 2013 Oct; 128(4):228-34. PubMed ID: 23461556
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenicity of zonisamide and other little-used antiseizure medications.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Perucca P; Lander CM; Eadie MJ
    Seizure; 2024 Apr; 117():198-201. PubMed ID: 38460459
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiseizure Medication Concentrations During Pregnancy: Results From the Maternal Outcomes and Neurodevelopmental Effects of Antiepileptic Drugs (MONEAD) Study.
    Pennell PB; Karanam A; Meador KJ; Gerard E; Kalayjian L; Penovich P; Matthews A; McElrath TM; Birnbaum AK;
    JAMA Neurol; 2022 Apr; 79(4):370-379. PubMed ID: 35157004
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The contribution of non-drug factors to fetal malformation in anti-seizure-medication-treated pregnancy.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Lander CM; Eadie MJ
    Epilepsy Behav; 2021 May; 118():107941. PubMed ID: 33852986
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dose dependence of fetal malformations associated with valproate.
    Vajda FJ; O'Brien TJ; Graham JE; Lander CM; Eadie MJ
    Neurology; 2013 Sep; 81(11):999-1003. PubMed ID: 23911758
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Changes over 24 years in a pregnancy register - Teratogenicity and epileptic seizure control.
    Vajda F; O'Brien T; Graham J; Hitchcock A; Perucca P; Lander C; Eadie M
    Epilepsy Behav; 2023 Nov; 148():109482. PubMed ID: 37839246
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fetal growth restriction and birth defects with newer and older antiepileptic drugs during pregnancy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    J Neurol; 2014 Mar; 261(3):579-88. PubMed ID: 24449062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Safety of Antiseizure Medication Monotherapy for Major Malformations.
    Cohen JM; Alvestad S; Cesta CE; Bjørk MH; Leinonen MK; Nørgaard M; Einarsdóttir K; Engeland A; Gissler M; Karlstad Ø; Klungsøyr K; Odsbu I; Reutfors J; Selmer RM; Tomson T; Ulrichsen SP; Zoega H; Furu K
    Ann Neurol; 2023 Mar; 93(3):551-562. PubMed ID: 36433783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Is carbamazepine a human teratogen?
    Vajda FJE; O'Brien TJ; Graham J; Lander CM; Eadie MJ
    J Clin Neurosci; 2016 Jan; 23():34-37. PubMed ID: 26521756
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure.
    Hernández-Díaz S; Straub L; Bateman BT; Zhu Y; Mogun H; Wisner KL; Gray KJ; Lester B; McDougle CJ; DiCesare E; Pennell PB; Huybrechts KF
    N Engl J Med; 2024 Mar; 390(12):1069-1079. PubMed ID: 38507750
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation of drug dose estimated from national prescription registers with mean blood level of antiseizure medication in pregnancy.
    Christensen J; Trabjerg B; Dreier JW
    Pharmacoepidemiol Drug Saf; 2024 Jun; 33(6):e5811. PubMed ID: 38783423
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Folic acid dose, valproate, and fetal malformations.
    Vajda FJE; O'Brien TJ; Graham JE; Hitchcock AA; Perucca P; Lander CM; Eadie MJ
    Epilepsy Behav; 2021 Jan; 114(Pt A):107569. PubMed ID: 33272896
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intrauterine exposure to carbamazepine and specific congenital malformations: systematic review and case-control study.
    Jentink J; Dolk H; Loane MA; Morris JK; Wellesley D; Garne E; de Jong-van den Berg L;
    BMJ; 2010 Dec; 341():c6581. PubMed ID: 21127116
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Treatment of Juvenile Myoclonic Epilepsy in Patients of Child-Bearing Potential.
    Serafini A; Gerard E; Genton P; Crespel A; Gelisse P
    CNS Drugs; 2019 Mar; 33(3):195-208. PubMed ID: 30747367
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.